Nicolas W. Shammas, MS, MD
Director, Midwest Cardiovascular Research Foundation
Genesis Heart Institute Affiliate
Cardiovascular Medicine PC
Davenport, IA
David Cohen, M.D.
Cardiovascular Consultants, P.C.
Lee's Summit, MO
John McB. Hodgson, MD, FSCAI
Chief, Academic Cardiology
Sante Personalized Preventative Healthcare
Phoenix, AZ
Module 1: Reduced Bleeding Complications During PCI
Nicolas W. Shammas, MS, MD
Module #2-Economic Benefits of Thrombin Inhibition During PCI
David Cohen, M.D.
Module #3- Early Sheath Removal in the Cath Lab
John McB. Hodgson, MD, FSCAI
This activity is designed for Invasive Cardiologists, Vascular Surgeons, Interventional Neurologists, Interventional Radiologists, Nurses and Technologists.
Module 1: Reduced Bleeding Complications During PCI
Upon completion of this educational activity, participants should be able to:
- review currently utilized anticoagulants in the cardiac cath lab and their approved and off-label applications
- review data from comparative trials on the effectiveness and safety of these anticoagulants
Module 2: Economic Benefits of Thrombin Inhibition During PCI
Upon completion of this educational activity, participants should be able to:
- describe the importance of early sheath removal in reducing bleeding events
- utilize pre-procedure planning for puncture site on the subsequent sheath removal options
Module 3: Early Sheath Removal in the Cath Lab
Upon completion of this educational activity, participants should be able to:
- describe the importance of early sheath removal in reducing bleeding events
- utilize pre-procedure planning for puncture site on the subsequent sheath removal options.
Module 1: Reduced Bleeding Complications During PCI
Pharmacists:
The North American Center for Continuing Medical Education (NACCME) is accredited by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education.
NACCME designates this continuing education activity for 1contact hour (0.1 CEU’s) of the American Council on Pharmaceutical Education. Universal Program Number 276-000-07-006-H04
A statement of credit will be issued via US Mail within 8 weeks after successful completion of the activity post-test. A passing score of 70% is required for successful completion.
Nurses:
ANCC: North American Center for Continuing Medical Education is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour(s). Provider #: 110-3-E-03.
Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1 contact hour.
Technologists:
SICP –Approved for one credit hour.
Module 2 Economic Benefits of Thrombin Inhibition During PCI
Pharmacists:
The North American Center for Continuing Medical Education (NACCME) is accredited by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education.
NACCME designates this continuing education activity for 1contact hour (0.1 CEU’s) of the American Council on Pharmaceutical Education. Universal Program Number 276-000-07-009-H01.
A statement of credit will be issued via US Mail within 8 weeks after successful completion of the activity post-test. A passing score of 70% is required for successful completion.
Nurses:
ANCC: North American Center for Continuing Medical Education is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour(s). Provider #: 110-3-E-03.
Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1 contact hour.
Technologists:
SICP –Approved for one credit hour.
Module #3 Early Sheath Removal in the Cath Lab
Pharmacists:
The North American Center for Continuing Medical Education (NACCME) is accredited by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education.”
NACCME designates this continuing education activity for 1contact hour (0.1 CEU’s) of the American Council on Pharmaceutical Education. Universal Program Number 276-000-07-008-H04.
A statement of credit will be issued via US Mail within 8 weeks after successful completion of the activity post-test. A passing score of 70% is required for successful completion.
Nurses:
ANCC: North American Center for Continuing Medical Education is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour(s). Provider #: 110-3-E-03.
Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1 contact hour.
Technologists:
SICP –Approved for one credit hour
Module 1: Direct Thrombin Inhibition During Peripheral Vascular Interventions
All faculty participating in Continuing Education programs sponsored by the North American Center for Continuing Medical Education are expected to disclose to the meeting audience any real or apparent conflict(s) of interest related to the content of their presentation. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants.
Doctor Shammas has disclosed that he has received grant/research support from The Medicines Company, and Schering-Plough. He is a member for the speakers’ bureau for The Medicines Company, Sanofi-Aventis and BMS.
Module 2: Use of Direct Thrombin Inhibitors during PPI for CLI, SFA and Fem-Pop Intervention
All those with control over the content of continuing education programs sponsored by NACCME are expected to disclose whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s). It is not assumed that these relationships will have an adverse impact on presentations; they are simply noted here to fully inform participants.
Doctor Cohen has disclosed that he has received research/grant support from The Medicines Company, Eli Lilly and BMS/Sanofi.
Module 3: Early Sheath Removal in the Cath Lab
All those with control over the content of continuing education programs sponsored by NACCME are expected to disclose whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s). It is not assumed that these relationships will have an adverse impact on presentations; they are simply noted here to fully inform participants.
Doctor Hodgson has disclosed that he has no significant financial relationship that could be perceived as a real or apparent conflict of interest in the context of the subject of his presentation.
This activity is supported by an educational grant from The Medicines Company.
Sponsored by the North American Center for Continuing Medical Education (NACCME).
Login
Email
Related Links
F.A.Q.
Contact Us
